|
|
On the morning of February 17, Shenzhen Pingshan District Governor Li Yong, Deputy District Governor Chen Huaping, Director of Science and Technology Innovation Bureau Huang Ming, Deputy Director of the Office of the District Party Committee (District government) Lin Shihua, Industry and Information Technology Bureau, and Market Supervision Administration Pingshan Bureau came to Shenzhen Pingshan Biotechnology Co., Ltd. to conduct research and development of anti-epidemic products. The company's general manager Lian Zhengxin and its R&D team warmly welcomed the visiting leaders. The novel coronavirus 2019-nCoV has high infectivity and wide transmission routes, and relevant in vitro diagnostic products are urgently needed to support rapid screening and diagnosis in medical institutions. As a sci-tech enterprise at the Torch Center of the Ministry of Science and Technology, it is a key industrial enterprise in Pingshan District. It actively undertakes social responsibility, and actively participates in the fight against the novel coronavirus in order to help the country fight against the epidemic, and promptly responds to the call for novel coronavirus prevention and control. During the research process, Lian Zhengxin, general manager of the company, reported the research and development of its anti-epidemic products to President Li at its management level. After the outbreak, it analyzed the relevant detection principles and methodologies of novel coronavirus 2019-nCoV reagents, initiated epidemic emergency measures, and set up a special research and development team. Based on its scientific and technological advantages, it actively develops related rapid diagnostic products to overcome the difficulties. The pre-test of 2019-nCoV detection kit (automatic liquid phase method) has been completed. This project relies on the company's existing automatic liquid phase reaction system technology platform to develop novel coronavirus detection reagents, and supports automated instruments, which can detect thousands of suspected case specimens in batches in one hour, with rapid and accurate detection. The novel test kit developed by the company is a hematological sample at its development level, and it is suitable for screening patients with novel coronavirus pneumonia in a broad range of medical institutions. It is simple and efficient to use and can be used in a wide range of medical institutions. Hematological samples can effectively reduce the risk of infection in medical care, and hematological detection can be combined with nucleic acid detection and CT examination for accurate diagnosis of patients, which is conducive to early diagnosis and exclusion of suspicious cases, and the detection is convenient and safe, which is suitable for large-scale screening in medical institutions at all levels.
Li District chief and his party arrived at the company for an inspection
Mr. Lian Zhengxin, general manager of Shenzhen Company, reported the development progress to the leaders of the district Party Committee and the district government
Governor Li affirmed and gave instructions to our company to carry out anti-epidemic work
Mr. Li and the relevant district leaders fully affirmed our R & D capability; For the current epidemic prevention and control, Li kindly asked the staff after returning to work to eat and supply masks and other issues; On behalf of the Pingshan District government, Mr. Li donated masks to our employees, which guaranteed the safe resumption of work. |
